Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.58 |
| ▸ | HPGD | P15428 | 3/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | GLA | P06280 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11067262 | 0.83 | KDM4E (0.80) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL11406037 | 0.83 | KDM4E (0.67) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL5683495 | 0.81 | LMNA (0.49) | KDM4EALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL6667765 | 0.81 | KDM4E (0.60) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL6667193 | 0.80 | KDM4E (0.57) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL5679721 | 0.79 | ALDH1A1 (0.75) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL5679313 | 0.78 | DRD3 (0.65) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL10920758 | 0.77 | KDM4E (0.60) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL11064244 | 0.77 | KDM4E (0.60) | KDM4EALDH1A1HPGDHSD17B10DRD3 | |
| SCHEMBL11026160 | 0.76 | ALDH1A1 (0.65) | KDM4EALDH1A1HPGDHSD17B10DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0831869-B1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 2006-02-08 | — | — | EP | disclosed |
| EP-0831869-A4 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS IN (US) | 1999-04-21 | — | — | EP | disclosed |
| EP-0831869-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | Elizanor Biopharmaceuticals, Inc. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996040190-A1 | DIPHOSPHONATE DERIVATIVES OF THERAPEUTIC AGENTS | ELIZANOR BIOPHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |